High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites
在免疫豁免部位发生的弥漫性大B细胞淋巴瘤中,致癌基因MYD88和CD79B突变的发生率很高。
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/bcj.2013.28
Kraan, W; Horlings, H M; van Keimpema, M; Schilder-Tol, E J M; Oud, M E C M; Scheepstra, C; Kluin, P M; Kersten, M J; Spaargaren, M; Pals, S T
B细胞
肿瘤
CD7
肿瘤免疫
CD79B
淋巴瘤
MYD88
细胞生物学
免疫/内分泌